• Clinical and Experimental Pediatrics
• /
• 제61권2호
• /
• pp.37-42
• /
• 2018

Hemolytic uremic syndrome (HUS) is often encountered in children with acute kidney injury. Besides the well-known shiga toxin-producing Escherichia coli-associated HUS, atypical HUS (aHUS) caused by genetic complement dysregulation has been studied recently. aHUS is a rare, chronic, and devastating disorder that progressively damages systemic organs, resulting in stroke, end-stage renal disease, and death. The traditional treatment for aHUS is mainly plasmapheresis or plasma infusion; however, many children with aHUS will progress to chronic kidney disease despite plasma therapy. Eculizumab is a newly developed biologic that blocks the terminal complement pathway and has been successfully used in the treatment of aHUS. Currently, several guidelines for aHUS, including the Korean guideline, recommend eculizumab as the first-line therapy in children with aHUS. Moreover, life-long eculizumab therapy is generally recommended. Further studies on discontinuation of eculizumab are needed.

• Biomolecules & Therapeutics
• /
• 제29권4호
• /
• pp.365-372
• /
• 2021

Type 2 diabetes mellitus (T2DM) leads to many health problems like diabetic nephropathy (DN). One of the key factors for chronic kidney disease and end-stage renal disease (ESRD) is T2DM. Extensive work is being done to delineate the pathogenesis of DN and to extend possible remedies. This review is intended to understand the nature of DN risk factors, progression, effects of glycemic levels, and stages of DN. We also explored the novel diagnostic and therapeutic approaches for DN such as gene therapy and stem cell treatments.

• Korean Journal of Radiology
• /
• 제20권6호
• /
• pp.894-908
• /
• 2019

Kidney transplantation is the treatment of choice for patients with end-stage renal disease, as it extends survival and increases quality of life in these patients. However, chronic allograft injury continues to be a major problem, and leads to eventual graft loss. Early detection of allograft injury is essential for guiding appropriate intervention to delay or prevent irreversible damage. Several advanced MRI techniques can offer some important information regarding functional changes such as perfusion, diffusion, structural complexity, as well as oxygenation and fibrosis. This review highlights the potential of multiparametric MRI for noninvasive and comprehensive assessment of renal allograft injury.

• Journal of Chest Surgery
• /
• 제49권6호
• /
• pp.427-434
• /
• 2016

Background: Recent studies have demonstrated the benefits of off-pump coronary bypass grafting over the on-pump technique in patients with chronic kidney disease (CKD). To further reduce the risk of acute kidney injury and the need for renal replacement therapy, even in patients undergoing off-pump coronary artery bypass grafting, we adopted protocol-based perioperative management for patients with CKD. Methods: From December 2012 to March 2015, 265 patients underwent isolated off-pump coronary artery bypass grafting. To analyze renal function in a stable condition, we excluded 12 dialysis-dependent end stage renal failure and 10 emergency or urgent cases. Among the remaining 243 patients, 208 patients had normal kidney function (normal group), and 35 patients had CKD (CKD group). Minimizing contrast exposure, ensuring adequate hydration, using strict drug dosage adjustment, and optimizing hemodynamic status were key elements of the protocol for the CKD group. Results: The risk of acute kidney injury was about ${\times}3$ higher in the CKD group than in the normal group (p=0.01). Estimated glomerular filtration rates and serum creatinine levels deteriorated until the third postoperative day in the CKD group. However, by adopting protocol-based perioperative management, this transient renal dysfunction recovered to preoperative levels by the fifth postoperative day without requiring renal replacement therapy in all cases. Conclusion: Off-pump coronary bypass surgery combined with this protocol-based perioperative management strategy in patients with non-dialysis-dependent CKD could mostly be performed without renal replacement therapy.

• Clinical and Experimental Pediatrics
• /
• 제54권1호
• /
• pp.36-39
• /
• 2011

Bartter syndrome (BS) is a clinically and genetically heterogeneous inherited renal tubular disorder characterized by renal salt wasting, hypokalemic metabolic alkalosis and normotensive hyperreninemic hyperaldosteronism. There have been several case reports of BS complicated by focal segmental glomerulosclerosis (FSGS). Here, we have reported the case of a BS patient who developed FSGS and subsequent end-stage renal disease (ESRD) and provided a brief literature review. The patient presented with classic BS at 3 months of age and developed proteinuria at 7 years. Renal biopsy performed at 11 years of age revealed a FSGS perihilar variant. Hemodialysis was initiated at 11 years of age, and kidney transplantation was performed at 16 years of age. The post-transplantation course has been uneventful for more than 3 years with complete disappearance of BS without the recurrence of FSGS. Genetic study revealed a homozygous p.Trp(TGG)610Stop(TGA) mutation in the CLCNKB gene. In summary, BS may be complicated by secondary FSGS due to the adaptive response to chronic salt-losing nephropathy, and FSGS may progress to ESRD in some patients. Renal transplantation in patients with BS and ESRD results in complete remission of BS.

• Journal of Genetic Medicine
• /
• 제17권1호
• /
• pp.39-42
• /
• 2020

The Senior-Loken syndrome was first described in 1961 as an oculo-renal disease consisting of familial juvenile nephronophthisis and Leber congenital amaurosis. It is a rare autosomal recessive disorder with a prevalence of 1:1,000,000 caused by mutations in nine genes (NPHP 1-8 and NPHP 10). Ocular manifestations (e.g., photophobia, nystagmus, and extreme hyperopia) occur within the first few years of life while renal manifestations (e.g., formation of multiple cysts impairing kidney function and end-stage renal disease) appear in late childhood to adolescence. Here, we report a case of a Filipino male presenting with rotatory nystagmus and progressive deterioration of vision since childhood. He had congenital amaurosis and juvenile nephronophthisis that progressed to end stage renal disease by age 19. All laboratory and imaging findings were consistent with chronic kidney disease. Molecular genetic testing of ciliopathy-related genes was performed revealing a homozygous mutation in exon 11 of the IQCB1/NPHP5 gene, c.1090C>T (p.Arg364^⁎). This sequence change created a premature translational stop signal resulting in a truncated protein product, nephrocystin-5 and its consequent loss of function. His symptoms eventually improved with initiation dialysis. The prognosis of Senior-Loken syndrome remains dismal and a high index of suspicion, early diagnosis and timely intervention of renal complications are warranted.

• Clinical and Experimental Pediatrics
• /
• 제59권4호
• /
• pp.202-204
• /
• 2016

A 15-year-old boy, who was diagnosed with Alport syndrome and end-stage renal disease, received a renal transplant from a living-related donor. On postoperative day 1, his daily urine output was 10,000 mL despite normal graft function. His laboratory findings including urine, serum osmolality, and antidiuretic hormone levels showed signs similar to central diabetes insipidus, so he was administered desmopressin acetate nasal spray. After administering the desmopressin, urine specific gravity and osmolality increased abruptly, and daily urine output declined to the normal range. The desmopressin acetate was tapered gradually and discontinued 3 months later. Graft function was good, and urine output was maintained within the normal range without desmopressin 20 months after the transplantation. We present a case of a massive polyuria due to transient deficiency of antidiuretic hormone with the necessity of desmopressin therapy immediately after kidney transplantation in a pediatric patient.

• Childhood Kidney Diseases
• /
• 제14권1호
• /
• pp.10-21
• /
• 2010

헤노흐-쇤라인 자반증의 전반적인 예후는 양호하나 심한 신염의 경우 말기신부전으로 진행될 위험이 높다. 최근 연구는 심한 헤노흐-쇤라인 자반증 신염을 가진 소아에서 조기 치료의 중요성을 강조하고 있으나 심한 자반증 신염의 치료는 맹검 대조 연구가 드물어 여전히 논쟁의 여지가 있다. 그럼에도, 정맥 고용량 메틸프레드니솔론 충격요법, 면역억제/세포독성 약제, 섬유소용해 치료, 항응고제, 항혈소판제, 혈장교환술같은 여러 강력한 치료가 심한 자반증 신염을 가진 소아에서 사용되어 왔다. 이 종설에서는 심한 자반증 신염을 가진 소아의 치료를 중점적으로 기술하였다.

• 환경생물
• /
• 제17권3호
• /
• pp.263-270
• /
• 1999

생쥐에 1 Gray(Gy)와 3 Gy의 방사선을 조사한 후 시간에 따라 골격근, 심장, 신장, 간 및 정소조직의 형태적 변화를 확인하였다. H-B(hematoxylin-eosin)염색 결과 apoptotic body는 다른 조직에 비해 간조직에서 쉽게 관찰되었고, 조사량에 비례하였으며 대부분의 조직에서 조사 후 1일에, 정소조직에서는 7일에 많이 관찰되었다. TUNEL (terminal deoxyribonucleotidyl transferase-mediated dUTP-digoxigenin nick end labeling)염색에 의한 결과도 동일하게 나타났다. 방사선 조사 후 단백질량은 신장을 제외한 나머지 조직에서 감소되었으며, 3 Gy를 조사한 경우 1 Gy보다 모든 조직에서 초기 2시간까지 감소되었으나 7일에는 모두 증가되었다. 젖산탈수소효소(EC 1.1.1.27, Lactate dehydrogenase: LDH) 활성은 모든 조직에서 증가되었고 1 Gy를 조사한 경우 초기에 더욱 증가되었으며 최고 활성은 3 Gy보다 빠른 시기에 나타났다. 골격근, 심장, 신장 및 정소조직은 일반적으로 $A_4$동위효소 활성이 감소되고 골격근과 심장은 $B_4$와 $A_2$$B_2$동위효소 활성이 증가되었으며 신장은 이질사량체의 활성이 증가되었다. 간은 $A_4$ 동위효소 활성이 높았고 정소는 C동위효소의 활성이 높았다. 따라서 LDH는 방사선 조사시 간조직을 제외한 나머지 조직에서 lactate oxidase로서 작용하여 호기적 대사가 우세한 것으로 사료된다.

• 정보처리학회논문지B
• /
• 제17B권6호
• /
• pp.437-444
• /
• 2010

본 논문에서는 한의학의 진단법인 사진법 중 망진(望診)이론을 기반으로 인체 오장 중 가장 중요한 장기의 하나인 신장의 질환 진단을 위해 영상처리기법을 적용하여 색과 신장 질환과의 상관성을 분석하는 방법을 제안하고자 한다. 이를 위해 안면 영상을 처리하고 분석하여 신장 질환에 따른 얼굴색의 색차를 시각화, 객관화하기 위한 방법을 제시하고자 한다. 특히 본 논문은 신장질환자 중 만성신부전으로 인해 혈액 투석 치료 중인 신장 기능 이상자 들을 대상으로 피 실험자 집단군을 구성하고 안면 영상 및 임상 자료를 수집하여 한의학적 망진 이론에서 신장과 관련된 얼굴 부위가 지각 이며 신장에 이상이 생길 경우 이 부위를 통해 흑색이 발현한다는 이론을 가설로 제시하고 안면 영상 중 지각 부위를 추출하는 알고리즘과 이 부위의 흑색의 변화를 측정 하는 방법에 대해 제안하고자 한다. 끝으로 임상 실험 및 자료 분석을 통해 제안한 방법의 유용성을 입증하고자 한다.